1.Bile Duct Stenosis & Intrahepatic Stones after a Transcather Hepatic Arterial Embolization: A case report .
Kyoung Soon PARK ; Sang Mok LEE ; Sung Wha HONG ; Hoong Jae JOO ; Joo Hyoung OH
Journal of the Korean Surgical Society 1998;54(3):441-446
Transcatheter hepatic arterial embolization (THAE) is one of the treatment modalities that can be applied to hepatocellular carcinomas (HCC) and metastatic tumors of the liver. Complications such as cholecystitis and gallbladder necrosis, are common with THAE, but liver and peripheral bile duct necrosis are rare, and intrahepatic stones with main bile duct necrosis have never been reported. To prevent intrahepatic spread during operative manupulation and to decrease the vascularity and size of the tumor, we performed a THAE on a huge-sized HCC five times before performing the hepatectomy. We succesfully undertook a right lobectomy after the THAE with lipiodol, gelform, and adriamycin. However, severe bile duct stricture and intrahepatic stones were confirmed during the operation.
Bile Ducts*
;
Bile*
;
Carcinoma, Hepatocellular
;
Cholecystitis
;
Constriction, Pathologic*
;
Doxorubicin
;
Ethiodized Oil
;
Gallbladder
;
Hepatectomy
;
Liver
;
Necrosis
2.Changes of Serum PSA after Alpha Adrenergic Blocker Treatment in Patients with BPH.
Korean Journal of Urology 2003;44(6):545-549
PURPOSE: To find if the alpha adrenergic blocker, terazosin, changes the PSA in BPH patients. MATERIALS AND METHODS: Patients with a PSA level over 2.5ng/ml, who visited our hospital with lower urinary tract symptoms, were reviewed, and excluded from having prostate cancer (n=101). After a routine check up for BPH, included history taking, a physical examination, laboratory examinations and a transrectal ultrasound, on their first visit, the PSA level and IPSS were checked again after 4 weeks of alpha adrenergic blocker (terazosin) management. RESULTS: The average size of the prostates and age of the patients were 40.6ml and 67.7 years, respectively. Overall, the PSA levels before the treatment was 4.12+/-2.03ng/ml, which decreased significantly, to 3.57+/-1.99ng/ml, after the terazosin treatment (p=0.002). The subgroups, divided by age, prostate size and IPSS score, all showed meaningful declines in the PSA levels, but with no statistical differences. CONCLUSIONS: The results from this research shows that terazosin treatment reduces the PSA levels in BPH patients complaining of lower urinary tract symptoms, and the changes in the pattern of the level may help to differentiate prostatic cancer, and reduce the incidence of a prostatic biopsy.
Adrenergic Antagonists*
;
Biopsy
;
Humans
;
Incidence
;
Lower Urinary Tract Symptoms
;
Physical Examination
;
Prostate
;
Prostate-Specific Antigen
;
Prostatic Hyperplasia
;
Prostatic Neoplasms
;
Ultrasonography
3.Esophago-Gastric Devascularization in Portal Hypertension.
Se Keon OH ; Sang Mok LEE ; Sung Wha HONG
Journal of the Korean Surgical Society 2005;69(4):293-298
PURPOSE: Bleeding from esophago-gastric varices needs urgent treatment. Esophageal varix bleeding usually was controlled by intervention, but rebleeding rate was high. Gastric varix bleeding is unable to be controlled by intervention. Recently, newly developed methods for varix bleeding controll have been used, but surgical intervention is still advocated. We report our experience with esophago-gastric devascularization for bleeding control in portal hypertension and its effectiveness. METHODS: This retrospective study was performed on 32 cases who underwent esophago-gastric devascularization in portal hypertension at Kyuung Hee University Hospital from Nov. 1990 to Feb. 2004. Author analyzed characteristics & patients, causes of portal hypertension, liver function reserve, operation methods, perioperative finding, complications and factors determining postoperative mortality. RESULTS: Sex ratios of male to female was 5.4:1. The ages were ranged from 25 to 70 years old with mean age of 50.5. Postoperative complication rate was 40.6% (13/32) and those were recovered by conservative management. There was one case of recurrent bleeding at 9months postperatively (3%). Mortality rate was 4% in Child-Pugh group A and B, and 57% in group C. The overall mortality rate was 15%. Preoperative hepatic reserve (P<0.05) & preoperative blood pressure (P<0.05) was a significant factors. A mean follow up period is 18.7 months. CONCLUSION: In our study, esophago-gastric devascularization in portal hypertension showed good results with 3% rebleeding rate and 85% overall survival rate. Esophago-gastric devascularization was effective method for esophago-gastric varix bleeding.
Aged
;
Blood Pressure
;
Esophageal and Gastric Varices
;
Female
;
Follow-Up Studies
;
Hemorrhage
;
Humans
;
Hypertension, Portal*
;
Liver
;
Male
;
Mortality
;
Postoperative Complications
;
Retrospective Studies
;
Sex Ratio
;
Survival Rate
;
Varicose Veins
4.Farber Disease Misdiagnosed as Hemangioendothelioma.
Sang Mok LEE ; Chaeyoun OH ; Sung Eun JUNG ; Hyun Young KIM
Journal of the Korean Association of Pediatric Surgeons 2016;22(2):54-58
Farber disease (FD) is a rare lysosomal storage disorder that shows autosomal recessive inheritance. We report the case of a 58-month-old girl with FD, who was misdiagnosed with epithelioid hemangioendothelioma. The patient had undergone five surgeries for sacrococcygeal masses and three surgeries for scalp masses owing to misdiagnosis. Here, we describe this rare case of FD.
Diagnostic Errors
;
Farber Lipogranulomatosis*
;
Female
;
Hemangioendothelioma*
;
Hemangioendothelioma, Epithelioid
;
Humans
;
Scalp
;
Wills
5.The Mechanisms of Resistance to TNF in TNF-Sensitive Cancer Cells Transfected with TNF-alpha Gene Using Retroviral Vector.
Hyuk Pyo LEE ; Yeon Mok OH ; Chul Gyu YOO ; Young Whan KIM ; Young Soo SHIM ; Sung Koo HAN
Tuberculosis and Respiratory Diseases 1997;44(3):547-558
BACKGROUND: Tumor necrosis factor(TNF) has been considered as an important candidate for cancer gene therapy based on it9 potent anti-tumor activity. However, since the efficiency of current techniques of gene transfer is not satisfactory, the majorities of current protocols is aiming the in vitro gene transfer to cancer cells and re-introducing genetically modified cancer cells to host In previous study, it was shown that TNF-sensitive cancer cells transfected with TNF-α CDNA would become highly resistant to TNF. Understanding the mechanisms of TNF-resistance in TNF-α gene transfected cancer cells would be an important step for improving the efficacy of cancer gene therapy as we]1 as for better understandings of tumor biology. This study was designed to evaluate the role of new protective protein synthesis in the acquired resistance to TNF of TNF-α gene transfected cancer cells. METHOD: We transfected TNF-α c-DNA to WEHI l64, a murine fibrosarcoma cell line, using retroviral vector (pLT12SN(TNF)) and confirm the expression of TNF with PCRf ELISA, MTT assay. Then we determined the TNF resistance of TNF gene transfected cells(WEHI 164-TNF) and the changes of TNF sensitivities after treatments with actinomycin D(transcription inhibitor) and cycloheximide(translation inhibitor). RESULTS: WEHI 164 which was sensitive to TNF became resistant to TNF after being trsnsfected with TNF-α gene and the resistance to TNF was partially reversed after treatment with actinomycin D, but not with cycloheximide. CONCLUSION: The acquired resistance to TNF after TNF-α gene transfection may be associated with synthesis of some protective proteins.
Biology
;
Cell Line
;
Cycloheximide
;
Dactinomycin
;
DNA, Complementary
;
Enzyme-Linked Immunosorbent Assay
;
Fibrosarcoma
;
Genes, Neoplasm
;
Necrosis
;
Transfection
;
Tumor Necrosis Factor-alpha*
;
Zidovudine*
6.New Trends in Innovative Technologies Applying Artificial Intelligence to Urinary Diseases
Jin Kyu OH ; Jun Young LEE ; Sung-Jong EUN ; Jong Mok PARK
International Neurourology Journal 2022;26(4):268-274
Artificial intelligence (AI) is used in various fields of medicine, with applications encompassing all areas of medical services, such as the development of medical robots, the diagnosis and personalized treatment of diseases, and personalized healthcare. Medical AI research and development have been largely focused on diagnosis, prediction, treatment, and management as an auxiliary means of patient care. AI is mainly used in the fields of personal healthcare and diagnostic imaging. In urology, substantial investments are being made in the development of urination monitoring systems in the personal healthcare field and diagnostic solutions for ureteral stricture and urolithiasis in the diagnostic imaging field. This paper describes AI applications for urinary diseases and discusses current trends and future perspectives in AI research.
7.Assessment of Fibrinolytic Activity and Antithrombin III Level during Fibrinolytic Therapy for Acure Myocardial Infarction.
Ki Ju HAN ; Ji Oh MOK ; Won Yong SHIN ; Kwang Hee LEE ; Chul Hyun KIM ; Tae Myoung CHOI ; Sung Woo LEE ; Sung Koo KIM ; Yong Joo KWON
Korean Circulation Journal 1997;27(12):1258-1264
BACKGROUND: In the acute phase of myocardial infarction, the hemostatic mechanism is known to be activated. However, it remains unclear whether increased activity of the hemostatic mechanism is only a marker of the acute thrombotic episode or precedes its appearance. It is also inapparent whether a hypercoagulable state persist for a prolonged period after the apparent resolution of these disorders. METHODS: In a group of 23 patients with acute myocardial infarction who received fibrinolytic therapy with urokinase(group A) or tPA(group B), the plasma level of fibrinogen, antithrombin compared to those of the 10 normal controls. RESULTS: The plasme level of fibrinogen was significantly decreased in both group A and B before and 4 to 24 hours after thrombolytic therapy compared to that of normal controls. But it was increased 7 to 14 days after thrombolytic therapy. In a few of the patients, the plasma level of FDP and D-dimer were positive before thrombolytic therapy and in the most patients they were positive 4 hours after thrombolytic therapy. The plasma level of AT-III was significantly increased in both group A and B before thrombolytic therapy compared with that of normal controls, but, after thrombolytic therapy, there was no significant change in its level. CONCLUSIONS: In the patients with acute myocardial infarction, the thrombolysis occurred before thrombolytic therapy and it lasted for 24 hours after thrombolytic therapy.
Antithrombin III*
;
Fibrinogen
;
Humans
;
Myocardial Infarction*
;
Plasma
;
Thrombolytic Therapy*
8.The effect of low-dose longterm erythromycin on bronchietasis.
Young Whan KIM ; Yeon Mok OH ; Man Pyo JUNG ; Chul Gyu YOO ; Sung Koo HAN ; Young Soo SHIM ; Keon Youl KIM ; Yong Chol HAN
Tuberculosis and Respiratory Diseases 1993;40(4):390-394
No abstract available.
Erythromycin*
9.TIMP-2 gene transfer via adenovirus inhibits the invasion of lung cancer cell.
Yeon Mok OH ; Jae Ho LEE ; Chul Gyu YOO ; Hee Soon CHUNG ; Young Whan KIM ; Sung Koo HAN ; Young Soo SHIM ; Choon Taek LEE
Tuberculosis and Respiratory Diseases 2000;49(2):189-197
BACKGROUND: Tissue inhibitor of metalloproteinase is a natural inhibitor that counteracts proteolytic enzymes essential to the invasion of cancer cell. Whether or not TIMP-2 gene transfer via adenovirus could inhibit the invasion of lung cancer cell in vitro was evaluated for the future purpose of gene therapy against lung cancer. METHODS: Recombinant adenvirus-TIMP-2(Ad-TIMP-2) was generated by homologeous recombination after pACCMV-TIMP-2 and pJM17 were cotransfected into 293 cell by standard calcium phosphate coprecipitate mathod. Calu-6, one of the most invasive lung cancer cells, was transduced with Ad-TIMP-2 or Ad-β-gal. An-chorage-independent growth and invasiveness were assessed by soft agar clonogenicity assay and invasion assay using two-chamber, well divided by matrigel. RESULTS: Ad-TIMP-2 transduced calu-6 cells produced bilolgically active TIMP-2 more than 50 times more than parental calu-6. TIMP-2 gene transfer did not suppress the in vitro tumorgenicity. However, two chamber well assay revealed that Ad-TIMP-2 transduction reduced the invasiveness of calu-6 efficiently (12% compared with parental cell) even at low 10moi. CONCLUSION: Even though TIMP-2 gene transfer did not inhibit in vitr tumorigenicity, it did inhibit invasion of lung cancer cell in vitro. The inhibition of invasion by Ad-TIMP-2 may be a useful strategy for the treatment of lung cancer.
Adenoviridae*
;
Agar
;
Calcium
;
Genetic Therapy
;
Humans
;
Lung Neoplasms*
;
Lung*
;
Parents
;
Peptide Hydrolases
;
Recombination, Genetic
;
Tissue Inhibitor of Metalloproteinase-2*
10.A case report of ameloblastic fibro-odontioma of the mandible.
Sang Chull LEE ; Yeo Gab KIM ; Dong Mok RYU ; Baek Soo LEE ; Sung Hwan OH ; Ok Byung YOON ; Kyu Tae PARK
Journal of the Korean Association of Oral and Maxillofacial Surgeons 1997;23(1):126-133
This is a case report and review of literature of a rare mixed odontogenic tumor, ameloblastic fibro-odontoma in the posterior area of the mandible. The ameloblastic fibro-odontoma which was developed by hyperplasia of dental epithelium and mesenchymal tissue. This tumor was classified from ameloblastic odontoma by Hooker, in 1967. At first and characterized by mixed appearance of odontoma and ameloblastic fibro-odontoma, But, on the point of pathologic feature, there are many controversial opinions among scholars up to the present. The patients of this case report was refereed to our department via the pedodontic department for the treatment of hard mass on the premolar area of the left mandible. And then, on the clinical and radiographic examination at first visit, we had tentative diagnosis that the lesion was benign mixed odontogenic tumor of defined mass margin that was amelblastic fibro-odontoma. The tumor mass was removed by surgical enucleation and curettage and extracted left mandibular second premolar which was impacted on the lesion. And the removed tumor mass was confirmed to ameloblastic fibro-odontoma on the post-operative biopsy. The patients has well done follow-up check postoperatively and shown no sign of recurrence up to the present.
Ameloblasts*
;
Bicuspid
;
Biopsy
;
Curettage
;
Diagnosis
;
Epithelium
;
Follow-Up Studies
;
Humans
;
Hyperplasia
;
Mandible*
;
Odontogenic Tumors
;
Odontoma
;
Recurrence